We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Guidance Could Help Drugmakers Win 'Regulatory Flexibility'
Guidance Could Help Drugmakers Win 'Regulatory Flexibility'
May 26, 2006
The FDA has issued an International Conference on Harmonisation (ICH) guidance that could help drugmakers win "regulatory flexibility" that potentially includes fewer postapproval submissions and a reduction of end-product release testing.